You're Invited: Beta Amyloid PET Imaging Webinar

Screen Shot 2018-10-12 at 8.37.01 AM.png

You're invited! Join us on Tuesday, October 30th for our FREE upcoming webinar on Beta Amyloid PET Imaging: Aiding in Diagnosis of Neurodegenerative Diseases. Here are the details you'll need:

Program Summary:

Dr. Padilla (above), a behavioral neurologist, has significant experience using Beta Amyloid PET imaging to evaluate patients with cognitive impairment. She will discuss the clinical impact of this procedure and review her experience presenting this Beta Amyloid diagnostic test to the appropriate patients and their caregivers, including situations where no insurance coverage is available.

Ms. Ruby, Head of National Sales for Life Molecular Imaging, will briefly review the characteristics of NeuraceqTM (florbetaben F18 Injection), a beta amyloid PET imaging agent.

Beta Amyloid PET Imaging: Aiding in Diagnosis of Neurodegenerative Diseases

  • Introduction

  • Dementia and Types

  • Alzheimer's Disease and Biomarkers

  • Amyloid PET Imaging

  • Research Studies

  • Case Studies

  • Quiz Questions

The Role of Neuraceq in Beta Amyloid PET Imaging

  • Neuraceq (florbetaben F18 Injection) Indication and Important Safety Information

  • Tracer Characteristics

  • Patient Rebate Program

About the Presenters

Claudia R. Padilla, MD

  • Medical Director for Research, Assistant Professor of Neurology

  • Baylor Scott & White AT&T Memory Center

  • Baylor University Medical Center

    Colleen Ruby, CNMT

  • Head of National Sales, US

  • Life Molecular Imaging Inc.

When: Tuesday, October 30th, 2018

Time: 12:30pm Eastern Daylight Time | 9:30am Pacific Daylight Time

Where to Sign Up:

What You'll Need: AltusLearn User Account (Username and Password). Don't have an account? Get a FREE account here!

You will be able to sign up for the webinar for free at the link provided below. We will send you a reminder closer to the webinar as well! See you there.

This program is commercially supported by

Screen Shot 2018-10-12 at 8.39.43 AM.png
Seth Werkheiser